Jeff Yass’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
Other funds holding CATX
Jeff Yass's CATX Position: Q3 2026 in Review
Jeff Yass increased its Perspective Therapeutics (CATX) stake by 187% in Q3 2026, buying an estimated $169K and bringing the position to 85,368 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #11555.
Jeff Yass first reported a position in CATX in Q2 2014 and has held it in 29 quarters since. The position peaked at $778K in Q1 2026. 120 funds tracked by Wall St. Rank hold CATX as of Q3 2026.
- Jeff Yass held 85,368 shares of Perspective Therapeutics worth $235K as of Q3 2026.
- Jeff Yass bought 55,579 Perspective Therapeutics shares in Q3 2026, an estimated $169K.
- Perspective Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11555 holding.
- Jeff Yass first reported a position in Perspective Therapeutics in Q2 2014 and has held it in 29 quarters since.
- Jeff Yass's Perspective Therapeutics position peaked at $778K in Q1 2026.
- 120 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.